Aspira operating loss narrows 51% to $7.9 million in FY25

Aspira Women's Health Inc.

Aspira Women's Health Inc.

AWHL

0.00
  • Aspira posted fiscal 2025 net loss of $12.8 million, narrowing 2%.
  • Revenue held nearly flat at $9.2 million.
  • Operating loss narrowed 51% to $7.9 million.
  • Management cited a 2025 strategic shift that cut headcount to 36 full-time employees from 66, helping reduce cash used in operations 40% to $7 million.
  • For 2026, Aspira expects a net loss and plans to keep executing cost-efficiency initiatives while increasing average unit pricing and unit sales.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000020), on April 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.